MGRX 주가 차트
MGRX 재무
Mangoceuticals Inc
$0.43
-6.57%
$-0.03
종가: Jul 06, 16:00:00 GMT-4
$0.44
2.45%
$0.01
애프터마켓: Jul 06, 18:26:49 GMT-4
뒤로
Mangoceuticals Inc (MGRX) 재무
주요 통계
이전 종가
$0.47
시가
$0.4428
일일 범위
$0.42 - $0.4502
52주 범위
$0.162 - $2.75
거래량
448.1K
평균 거래량
8.8M
배당수익률
--
EPS(TTM)
-1.61
시가총액
$7.7M
MGRX란 무엇인가요?
Mangoceuticals, Inc. engages in developing, marketing, and selling men's wellness products and services via a telemedicine platform. The company is headquartered in Dallas, Texas. The company went IPO on 2023-03-21. The company is advancing its proprietary antiviral compound MGX-0024. The firm offers pharmaceutical-based products specifically related to the treatments of erectile dysfunction (ED), hair growth, hormone replacement therapies, and weight management. The company has developed and is commercially marketing a brand of ED products under the brand name Mango; a brand of hair loss products under the brand name Grow; a brand of hormone balance and therapy products under the name Mojo, and a brand of weight loss products under the brand name Slim. Prime by MangoRx is a TRT product available by prescription. The Mango ED product includes the three ingredients: Either Sildenafil (the active ingredient in Viagra) or Tadalafil (the active ingredient in Cialis), and Oxytocin.
